Improving cancer treatment with cyclotron produced radionuclides. Progress report [electronic resource].
- Washington, D.C. : United States. Dept. of Energy, 1993.
Oak Ridge, Tenn. : Distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy.
- Physical Description:
- 23 pages : digital, PDF file
- Additional Creators:
- United States. Department of Energy and United States. Department of Energy. Office of Scientific and Technical Information
- Restrictions on Access:
- Free-to-read Unrestricted online access
- This report describes our continuing long term goal of promoting nuclear medicine applications by improving the scientific basis for tumor diagnosis, treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The program includes 3 interactive components: Radiochemistry/Cyclotron; Pharmacology; and Immunology. An essential strategy is as follows: novel radionuclides and radiotracers developed in the Radiochemistry/Cyclotron section will be employed in the Pharmacology and Immunology sections during the next year. The development of novel radionuclides and tracers is of course useful in and of itself, but their utility is greatly enhanced by the interaction with the immunology and pharmacology components of the program.
- Report Numbers:
- E 1.99:doe/er/60407--t2
- Other Subject(s):
- Published through SciTech Connect.
Larson, S.M.; Finn, R.D.
Memorial Sloan-Kettering Cancer Center, New York, NY (United States)
- Type of Report and Period Covered Note:
- Annual; 01/01/1993 - 12/31/1994
- Funding Information:
View MARC record | catkey: 14760411